Patent ID: 8771698
Filing Date: 2014-07-08
Classification: A61K,A61P,C07K,C12Q,G01N

Abstract:
1. A method for determining whether an agent may be useful for inhibiting the interaction between herpesvirus UL24 and non-muscle myosin type IIa (NM2a), wherein said method comprises contacting the UL24 polypeptide of SEQ ID NO:2 and the NM2a polypeptide of SEQ ID NO:4 in the presence of said agent, and determining whether the interaction between said UL24 and NM2a polypeptides is inhibited in the presence of said agent, wherein inhibition of the interaction between said UL24 and NM2a polypeptides in the presence of said agent is indicative that said agent may be useful for inhibiting the interaction between UL24 and NM2a.